Agencies working with Russia to set biosimilar standards

05/20/2013 | In-PharmaTechnologist.com

The World Health Organization, national regulatory agencies and international pharmaceutical associations met in Russia to set standards for the manufacture of biologic and biosimiliar products in that country. A key focus is establishing definitions and regulations for biosimilars, which are not yet recognized as distinct products under Russian law.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI